Guanfacine Extended Release and Mindfulness in Traumatically Stressed Children and Adolescents Study
Phase of Trial: Phase IV
Latest Information Update: 10 Dec 2019
Price : $35 *
At a glance
- Drugs Guanfacine (Primary)
- Indications Traumatic stress disorders
- Focus Therapeutic Use
- 05 Dec 2019 Status changed from recruiting to discontinued.
- 15 Mar 2019 Planned primary completion date changed from 1 May 2019 to 1 May 2020.
- 15 Mar 2019 Status changed from not yet recruiting to recruiting.